Skip to main content
HairCited

PRP-Therapie für Androgenetische Alopezie

A

Basierend auf 57 Studien (13 meta-analyses, 6 RCTs) mit 6,423 Teilnehmern insgesamt. 51/57 Studien zeigen positive Effekte.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dprp\u002Dtherapy\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

PRP therapy is strongly supported by extensive research as a procedure that may help improve hair density in androgenetic alopecia, with 13 meta-analyses confirming positive effects.

  • 57 studies with 13 meta-analyses — one of the most reviewed procedures for hair loss
  • 89% of studies show positive effects on hair density and growth
  • Multiple protocols show benefit: standalone PRP, PRP + microneedling, and PRP + minoxidil
  • No standardized preparation protocol exists, leading to some variability in outcomes

Key Study Findings

Randomized Controlled Trial n=27 12 weeks Single-blind
Platelet-Rich Plasma Treatment for Endocrine-Induced Alopecia and Persistent Chemotherapy-Induced Alopecia in Breast Cancer Survivors: A …
Dose: Monthly for 3 months vs.: Untreated side of scalp (split-scalp) Outcome: Global assessment scale change at week 12 Wirkung: +1.2 GAS; +21 hairs/cm2 treated vs +16 untreated p < 0.001 (GAS); p > 0.05 (bet

Population: Breast cancer survivors with EIA or pCIA

Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: women with androgenetic alopecia (female pattern hair loss)

Systematic Review
Relative efficacy of minoxidil in combination with other treatments for androgenic alopecia: a network meta-analysis …
Dose: None vs.: Minoxidil alone; Bayesian NMA of 20 study groups Outcome: Hair density change (SUCRA ranking) Wirkung: PRP+bFGF+minox SUCRA=93.06%; +35.12 hairs/cm² None

Population: Patients with AGA (network meta-analysis of RCTs)

Review
Promises and Pitfalls of Regenerative Therapies for Androgenetic Alopecia: Platelet-Rich Plasma, Photobiomodulation, Stem Cells, and …
Dose: None vs.: None Outcome: None Wirkung: None None

Population: Review of regenerative therapies for AGA (2020-2025)

Randomized Controlled Trial n=30
A Prospective and Comparative Study to Explore the Effects of Platelet-Rich Plasma in Hair Transplantation …
Dose: None vs.: Drug therapy (minoxidil + finasteride/spironolactone) only Outcome: Follicle survival rate, growth rate, hair strength Wirkung: None None

Population: Patients with androgenetic alopecia

Controlled Clinical Trial n=41 12 weeks Open-label
Effectiveness of Autologous Platelet-Rich Plasma for Androgenetic Alopecia: A Double-Center, Non-Controlled, Randomized Clinical Study in …
Dose: 3 sessions at 4-week intervals vs.: Pre-treatment baseline (single-arm) Outcome: Hair density change Wirkung: 40.76 to 66.00 hairs/cm2 <0.05

Population: Vietnamese patients with androgenetic alopecia

Key Statistics

144

Studien

8892

Teilnehmer

Positive

A

Bewertung

Referenced Papers

Journal of cutaneous … 2025 2 Zitierungen
Annals of dermatology 2025
International journal of … 2024 39 Zitierungen
Journal of cosmetic … 2024 12 Zitierungen
Journal of cosmetic … 2024 11 Zitierungen
Facial plastic surgery … 2024 8 Zitierungen
Revue medicale suisse 2024 2 Zitierungen
Clinical, cosmetic and … 2023 58 Zitierungen
American journal of … 2023 41 Zitierungen
International journal of … 2023 5 Zitierungen
Clinics in plastic … 2023 1 Zitierungen
Drug design, development … 2022 70 Zitierungen
Faculty reviews 2022 44 Zitierungen
Dermatology and therapy 2022 43 Zitierungen
Journal of cosmetic … 2022 35 Zitierungen
The journal of … 2022 22 Zitierungen
Dermatologic surgery : … 2022 15 Zitierungen
Skinmed 2022 3 Zitierungen
American family physician 2022 2 Zitierungen
Facial plastic surgery … 2022
Journal of cosmetic … 2021 23 Zitierungen
Indian dermatology online … 2021 17 Zitierungen
The Senior care … 2021 2 Zitierungen
Expert opinion on … 2020 147 Zitierungen
Facial plastic surgery … 2020 36 Zitierungen
Indian dermatology online … 2020 33 Zitierungen
Dermatologic surgery : … 2020 32 Zitierungen
Journal of drugs … 2020 11 Zitierungen
Dermatologic surgery : … 2019 68 Zitierungen
Aesthetic plastic surgery 2019 45 Zitierungen
Journal of cosmetic … 2019 30 Zitierungen
Dermatologic therapy 2019 14 Zitierungen
Indian journal of … 2019 10 Zitierungen
Skinmed 2019 7 Zitierungen
Dermatologic clinics 2019 7 Zitierungen
International journal of … 2018 129 Zitierungen
Journal of the … 2018 114 Zitierungen
Facial plastic surgery … 2018 43 Zitierungen
International journal of … 2018 42 Zitierungen
Facial plastic surgery … 2018 42 Zitierungen
Dermatology online journal 2018 27 Zitierungen
Journal of stomatology, … 2017 30 Zitierungen
Stem cell investigation 2017 27 Zitierungen
Expert opinion on … 2017 22 Zitierungen
International journal of … 2015 79 Zitierungen
Current opinion in … 2015 21 Zitierungen
Journal of cutaneous … 2014 168 Zitierungen
Dermatologic surgery : … 2014 140 Zitierungen
Expert opinion on … 2014 57 Zitierungen
Journal of nutrition … 2008 32 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

hairloss:
3-4 sessions, 4-6 weeks apart

Obergrenze: Not applicable

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
Monthly for 3 months 12 weeks Neutral 27
None -- Neutral --
None -- Positive --
None -- Mixed --
None -- Positive 30
3 sessions at 4-week intervals 12 weeks Positive 41
Oral minoxidil (low-dose); topical minoxidil 5% 32 weeks Positive 75
3 monthly PRP sessions 24 weeks Neutral 20

Beste Einnahmezeit: In-clinic procedure; avoid washing hair for 24 hours after treatment

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Injection site pain and tenderness
  • Scalp swelling and redness (1-2 days)
  • Headache following treatment
  • Rare: infection at injection site

Bekannte Wechselwirkungen

  • NSAIDs and aspirin (discontinue 1 week before PRP; affect platelet function)
  • Anticoagulants (may increase bruising; consult physician)
  • Corticosteroid injections (may reduce PRP effectiveness)

Tolerierbare Höchstaufnahmemenge: Not applicable

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does PRP-Therapie help with Androgenetische Alopezie?
Based on 144 studies with 8,892 participants, there is strong evidence from multiple clinical trials that PRP-Therapie may support Androgenetische Alopezie management. Our evidence grade is A (Strong Evidence).
How much PRP-Therapie should I take for Androgenetische Alopezie?
Studies have used various dosages. A commonly studied range is 3-4 sessions, 4-6 weeks apart. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of PRP-Therapie?
Reported side effects may include Injection site pain and tenderness, Scalp swelling and redness (1-2 days), Headache following treatment, Rare: infection at injection site. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for PRP-Therapie and Androgenetische Alopezie?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 144 peer-reviewed studies with 8,892 total participants. The overall direction of effect is positive.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.